Skip to main content
. 2026 Sep 17;19(9):1476. doi: 10.3390/ph19091476
AuNPsp gold nanoparticle spherical
AuNPst gold nanoparticle star
AuNPr gold nanoparticle rod
Au@PDA-RGD NPs RGD peptide-conjugated polydopamine-coated gold nanostars
AuNS-TCS thiolated chitosan-coated gold nanostars
CT computed tomography
Ce6 chlorin e6
CB [7] cucurbit [7] uril
CPT camptothecin
DTTC 3,3′-diethylthiatricarbocyanine
EM electromagnetic
ECL enhanced electrochemiluminescence
EV-GNS extracellular vesicle–gold nanostar
EPR enhanced permeability and retention
AuNSs gold nanostars
GNS-FA folic acid-functionalized gold nanostars
g-CN graphitic carbon nitride
HApt-AuNS anti-HER2 aptamer-functionalized gold nanostars
HAuNSs@Dox-Pol doxorubicin-loaded hollow gold nanostars
HCC hepatocellular carcinoma
HEPES 2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid
HNSCC head and neck squamous cell carcinoma
IBC inflammatory breast cancer
LSPR localized surface plasmon resonance
Micro STEM micro scanning transmission electron microscopy
MRI magnetic resonance imaging
MR magnetic resonance
MGNs multimodal gold nanostars
MSCs mesenchymal stem cells
MAuNSs mesoporous silica-coated gold nanostars
NIR near infrared
NK natural killer
PDT photodynamic therapy
PTT photothermal therapy
PAI photoacoustic imaging
PET positron emission tomography
RECIST Response Evaluation Criteria in Solid Tumors
ROS reactive oxygen species
R/P-cGNS red blood cell and platelet membrane-coated gold nanostars loaded with curcumin
RGD-Au DSNSs RGD-modified dendrimer-stabilized gold nanostars
SERS surface-enhanced Raman scattering
SYMPHONY synergistic immuno-photothermal nanotherapy
SEAD selected area diffraction
TCO trans-cyclooctene
TAT targeted alpha-particle therapy
TNBC triple-negative breast cancer
X-Ray X-ray diffraction
ZIF-8 zeolitic imidazole framework-8